Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PDT with Visudyne for Retinoblastoma
NCT04429139Completed
- Sponsor
- Sun Yat-sen University
- Start
- Feb 2011
- Primary completion
- May 2018
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
Open-label, single-arm trial of verteporfin in retinoblastoma (Rb), sponsored by Sun Yat-sen University. Primary endpoint: Eye enucleation at 3 years. Started Feb 2011; status: completed.
02
Drugs
verteporfin
03
Conditions
retinoblastoma (Rb)
Beyond the preview
Go deeper on NCT04429139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04429139.